The effects of lineage differentiation into pancreatic beta-cells on the immunogenicity of amniotic fluid stem cells.
Category
FP7 Project with U.S. partner
Short name and number
OXFORDWINSTON (221850)
Area
Health
Description
The use of stem cells for curing disease and ending disabilities may change the medical treatment in this century. However, there are some major roadblocks that need to be resolved before these cells are implemented in ordinary medical care.
Participating Countries
United Kingdom and United States.
Name of US Partner
WAKE FOREST UNIVERSITY HEALTH SCIENCES
Contact
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (UK) / DOLTON Monica